Belkys Candelaria Gómez

Belkys Candelaria Gómez

Auto-generated profile, based on publicly available information

Belkys Candelaria Gómez

Hospital Pediátrico Pepe Portilla. Departamento Provincial de Genética Médica, Pinar del Río, Cuba

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Salud, Ciencia y Tecnología
Verified
Journal Article
Open access
PDF file
DODeysi Licourt Otero
Deysi Licourt Otero
MLMelissa Toledo Licourt
Melissa Toledo Licourt
BGBelkys Candelaria Gómez
Belkys Candelaria Gómez
IHIlena Aurora Díaz Hernández
Ilena Aurora Díaz Hernández
Introduction: myotonic dystrophy type 1 is an autosomal dominant genetic disease with highly variable expressivity. Among the systemic alterations that are part of the clinical manifestations are neurodegeneration and premature aging, which is why it is part of progeroid syndromes. Objective: to describe progeroid dermatological manifestations in type 1 myotonic dystrophy. Case report: 44-year-old patient who, at the age of 9, confirmed a clinical diagnosis of myotonic dystrophy type 1. A family history with the same genetic disorder was collected. It presents dysmorphic signs in the skull, face, extremities and in different organs, among which are bilateral sensorineural deafness, early-onset cataracts, as well as dermatological manifestations such as seborrheic dermatitis and other lesions reminiscent of ichthyosis. Conclusions: DM1 is often referred to as a progeroid syndrome, which implies assuming that it exposes the usual underlying mechanisms of aging that are also those that participate in the pathogenesis of DM1 and in turn justify the dermatological manifestations observed

10 December 2023 in SCT Proceedings in Interdisciplinary Insights and Innovations
Verified
Journal Article
Open access
PDF file
PMPrisca Saray Nuñez Millan
Prisca Saray Nuñez Millan
BGBelkys Candelaria Gómez
Belkys Candelaria Gómez
MRMaría Beatriz Iglesias Rojas
María Beatriz Iglesias Rojas
Introduction: Identifying the genetic preconceptional risk in the context of community genetics will allow developing protective interventions and minimizing genetic risks in all their aspects. Objective: to design an educational strategy aimed at the prevention and follow-up of genetic preconceptional risk in the municipality of Consolación del Sur, during the year 2022. Method: an observational, descriptive, cross-sectional research was carried out, the universe coincides with the sample of 831 women evaluated in the municipal consultation of genetic preconceptional risk. Theoretical, empirical and descriptive statistical methods were used, given in absolute and relative numbers. Results: 31.41% of the women were evaluated with increased genetic preconceptional risk, 51.19% were due to congenital defects followed by chromosomopathies and hereditary conditions in 15.23%. Based on the diagnosis obtained, a strategy with a community approach is proposed to reduce the risk. Conclusions: The evaluation of preconceptional risk before pregnancy is a challenge of prenatal care, allowing the development of intervention strategies through preventive educational actions aimed at the management and reduction of the main risks.

5 April 2024 in SCT Proceedings in Interdisciplinary Insights and Innovations
Verified
Journal Article
Open access
PDF file
DODeysi Licourt Otero
Deysi Licourt Otero
MLMelissa Toledo Licourt
Melissa Toledo Licourt
BGBelkys Candelaria Gómez
Belkys Candelaria Gómez
IHIlena Aurora Díaz Hernández
Ilena Aurora Díaz Hernández
Introductions: myotonic dystrophy type 1 is a genetic disorder with great clinical variability in which there is a positive association between the number or size of the cytosine, thymine, guanine triplet repeats and the severity of the manifestations. The disorder exhibits an intergenerational anticipation phenomenon that explains the earlier age of onset of signs and the greater expression of clinical signs. Objetive: to describe the prenatal manifestations of myotonic dystrophy type 1. Clinical case: 22-year-old female patient with a diagnosis of DM1 since she was 6 years old and with a family history of the disorder through the mother's line who came to the clinic with a 22-week pregnancy. Multiple signs were reported when performing prenatal fetal ultrasonography due to: presentation maintained in the pelvic region, slight ventriculomegaly, lower limbs extended and with ventral flexion on the trunk as well as both equinus feet. The birth occurred with a gestation period of 33.6 weeks, the Apgar test was 3-3-3, birth weight 2450 gr. Conclusions: the severity of the congenital form of myotonic dystrophy type 1 requires close monitoring by a multidisciplinary team that extends from the preconception stage, to detect the possible complications described that worsen the quality of life of patients and their families, and may even to the death of both the mother and the newborn, especially during the first year of life.

7 April 2024 in SCT Proceedings in Interdisciplinary Insights and Innovations
Verified
Journal Article
Open access
PDF file
DODeysi Licourt Otero
Deysi Licourt Otero
MLMelissa Toledo Licourt
Melissa Toledo Licourt
BGBelkys Candelaria Gómez
Belkys Candelaria Gómez
IHIlena Aurora Díaz Hernández
Ilena Aurora Díaz Hernández
Introductions: myotonic dystrophy type 1 is a genetic disorder with great clinical variability in which there is a positive association between the number or size of the cytosine, thymine, guanine triplet repeats and the severity of the manifestations. The disorder exhibits an intergenerational anticipation phenomenon that explains the earlier age of onset of signs and the greater expression of clinical signs. Objetive: to describe the prenatal manifestations of myotonic dystrophy type 1. Clinical case: 22-year-old female patient with a diagnosis of DM1 since she was 6 years old and with a family history of the disorder through the mother's line who came to the clinic with a 22-week pregnancy. Multiple signs were reported when performing prenatal fetal ultrasonography due to: presentation maintained in the pelvic region, slight ventriculomegaly, lower limbs extended and with ventral flexion on the trunk as well as both equinus feet. The birth occurred with a gestation period of 33.6 weeks, the Apgar test was 3-3-3, birth weight 2450 gr. Conclusions: the severity of the congenital form of myotonic dystrophy type 1 requires close monitoring by a multidisciplinary team that extends from the preconception stage, to detect the possible complications described thatworsen the quality of life of patients and their families, and may even to the death of both the mother and the newborn, especially during the first year of life.

10 December 2023 in SCT Proceedings in Interdisciplinary Insights and Innovations
Verified
Journal Article
Open access
PDF file
PMPrisca Saray Nuñez Millan
Prisca Saray Nuñez Millan
BGBelkys Candelaria Gómez
Belkys Candelaria Gómez
MRMaría Beatriz Iglesias Rojas
María Beatriz Iglesias Rojas
Introduction: Community genetics consultation has spread across the country. Genes and environment can influence the risk of genetic disease. It integrates strategies for prevention and detection of population genetic risk from primary health care. Objective: To characterize the behavior of prenatal genetic risk and to design a genetic counseling strategy with community outreach on increased prenatal genetic risk. Methods: A descriptive and retrospective cross-sectional study was carried out from January 2020 to December 2022 in the municipality of Consolación de Sur. The universe was constituted by 3887 pregnant women who had been admitted to the community genetic consultation and the sample consisted of 1863 women evaluated with increased risk. The processed information was shown in frequency distribution tables. Percentage analysis of the results and the Delphi method were used for the technical validation of the genetic counseling proposal based on its basic elements and ethical aspects. Results: The pregnant women evaluated with increased genetic risk represented 47.92%, the most important risk being chromosomal alterations in 49.89%, followed by congenital defects in 32.51% and hereditary conditions in 11.57%. Extreme ages constituted a health problem, with adolescent girls 15.41% being the most frequent. We propose strategy to optimize attention to increased prenatal risk. Conclusions: The evaluation of pregnant women allowed the identification of increased risk factors and the design of a genetic counseling strategy with a community approach, helping to improve prenatal care.